UB Paderborn / Katalog / Suche / in CDI

RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma

Clinical cancer research, 2021-01, Vol.27 (2), p.645-655

2021

Volltextzugriff (PDF)

Mid-term Outcomes of Hybrid and Endovascular Aortic Arch Surgery

EJVES vascular forum, 2024, Vol.61, p.S19-S20

2024

Volltextzugriff (PDF)

ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi17-vi18

2017

Volltextzugriff (PDF)

Mortality and Bleeding Complications of COVID-19 Critically Ill Patients with Venous Thrombo-Embolism

EJVES vascular forum, 2022, Vol.54, p.e52-e52

2022

Volltextzugriff (PDF)

ACTR-48. AN APPRAISAL OF THE IMPACT ON SURVIVAL OF NEOADJUVANT TREATMENTS DELAYING RADIOTHERAPY IN ‘ONLY-BIOPSIED GLIOBLASTOMA’ TRIALS CONDUCTED BY THE GEINO GROUP COMPARED TO PATIENTS TREATED WITH THE STUPP’S REGIME. EXPERIENCE OF THE GEINO AND THE GLIOCAT GROUP

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi11-vi11

2017

Volltextzugriff (PDF)

COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism

European journal of vascular and endovascular surgery, 2021-04, Vol.61 (4), p.628-634

2021

Volltextzugriff (PDF)

Thoracic Aortic Mural Thrombus, Right Ventricular Clot and Pulmonary Embolism in a Patient With COVID-19 Pneumonia

Vascular and endovascular surgery, 2021-04, Vol.55 (3), p.273-276

2021

Volltextzugriff (PDF)

Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study)

Clinical & translational oncology, 2009-04, Vol.11 (4), p.221-227

2009

Volltextzugriff (PDF)

Groin surgical site infection incidence in vascular surgery with intradermal suture versus metallic stapling skin closure: A study protocol for a pragmatic open-label parallel-group randomized clinical trial (VASC-INF trial)

Medicine (Baltimore), 2022-12, Vol.101 (50), p.e31800-e31800

2022

Volltextzugriff (PDF)

Efficacy of radiotherapy for malignant gliomas in elderly patients

International journal of radiation oncology, biology, physics, 1998-12, Vol.42 (5), p.977-980

1998

Volltextzugriff (PDF)

Mortality and bleeding complications of COVID-19 critically ill patients with venous thromboembolism

International angiology, 2022-02, Vol.41 (1), p.1

2022

Volltextzugriff (PDF)

Long-term responders to first-line bevacizumab-based therapy in metastatic breast cancer (MBC) patients: Results of the observational study LORENA

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12563-e12563

2017

Volltextzugriff (PDF)

Bevacizumab in combination with TMZ in patients with recurrent GBM: Final OS and PFS analysis

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2087-2087

2013

Volltextzugriff (PDF)

GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of PF-299804 (dacomitinib), a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutation

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS2110-TPS2110

2014

Volltextzugriff (PDF)

FAIRLANE: A phase II randomized, double-blind, study of the Akt inhibitor ipatasertib (Ipat, GDC-0068) in combination with paclitaxel (Pac) as neoadjuvant treatment for early stage triple-negative breast cancer (TNBC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS1112-TPS1112

2015

Volltextzugriff (PDF)

Reparación híbrida de arco aórtico tipo I (sin sustitución aorta ascendente) y tipo II (con sustitución aorta ascendente) como puente a TEVAR

Cirugía cardiovascular, 2024-03

2024

Volltextzugriff (PDF)

AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: OS analysis

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e11535-e11535

2012

Volltextzugriff (PDF)

Value of circulating epithelial tumor cells and circulating endothelial cells (CTCs/CECs) in patients with HER2-negative recurrent or metastatic breast cancer treated with bevacizumab (B) in combination with paclitaxel (P) and gemcitabine (G) as first-line therapy (AVALUZ trial)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e21088-e21088

2012

Volltextzugriff (PDF)

Study of the usefulness of angiotensin type 1 receptor (AGTR1) as a possible response predictor in patients with metastatic breast cancer (mBC) subjected to chemotherapy and treatment with bevacizumab (AVALUZ Study)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10608-10608

2012

Volltextzugriff (PDF)

Bioengineering commensal bacteria-derived outer membrane vesicles for delivery of biologics to the gastrointestinal and respiratory tract

Journal of extracellular vesicles, 2019-12, Vol.8 (1), p.1632100-n/a

2019

Volltextzugriff (PDF)

Mixed Iodide–Bromide Methylammonium Lead Perovskite-based Diodes for Light Emission and Photovoltaics

The journal of physical chemistry letters, 2015-09, Vol.6 (18), p.3743-3748

2015

Volltextzugriff (PDF)

A first order hyperbolic framework for large strain computational solid dynamics. Part I: Total Lagrangian isothermal elasticity

Computer methods in applied mechanics and engineering, 2015-01, Vol.283, p.689-732

2015

Volltextzugriff (PDF)

Reduction of faecal immunochemical test false‐positive results using a signature based on faecal bacterial markers

Alimentary pharmacology & therapeutics, 2019-06, Vol.49 (11), p.1410-1420

2019

Volltextzugriff (PDF)

El futbol, nova potència social, econòmia i política

Revista de Girona, 1995 (171)

Gil i Bonancia, Miquel

1995

Volltextzugriff (PDF)

L'arxiver de la Diputació

Revista de Girona, 1993 (158)

Gil i Bonancia, Miquel

1993

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma

Mid-term Outcomes of Hybrid and Endovascular Aortic Arch Surgery

ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA

Mortality and Bleeding Complications of COVID-19 Critically Ill Patients with Venous Thrombo-Embolism

ACTR-48. AN APPRAISAL OF THE IMPACT ON SURVIVAL OF NEOADJUVANT TREATMENTS DELAYING RADIOTHERAPY IN ‘ONLY-BIOPSIED GLIOBLASTOMA’ TRIALS CONDUCTED BY THE GEINO GROUP COMPARED TO PATIENTS TREATED WITH THE STUPP’S REGIME. EXPERIENCE OF THE GEINO AND THE GLIOCAT GROUP

COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism

Thoracic Aortic Mural Thrombus, Right Ventricular Clot and Pulmonary Embolism in a Patient With COVID-19 Pneumonia

Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study)

Groin surgical site infection incidence in vascular surgery with intradermal suture versus metallic stapling skin closure: A study protocol for a pragmatic open-label parallel-group randomized clinical trial (VASC-INF trial)

Efficacy of radiotherapy for malignant gliomas in elderly patients

Mortality and bleeding complications of COVID-19 critically ill patients with venous thromboembolism

Long-term responders to first-line bevacizumab-based therapy in metastatic breast cancer (MBC) patients: Results of the observational study LORENA

Bevacizumab in combination with TMZ in patients with recurrent GBM: Final OS and PFS analysis

GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of PF-299804 (dacomitinib), a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutation

FAIRLANE: A phase II randomized, double-blind, study of the Akt inhibitor ipatasertib (Ipat, GDC-0068) in combination with paclitaxel (Pac) as neoadjuvant treatment for early stage triple-negative breast cancer (TNBC)

Reparación híbrida de arco aórtico tipo I (sin sustitución aorta ascendente) y tipo II (con sustitución aorta ascendente) como puente a TEVAR

AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: OS analysis

Value of circulating epithelial tumor cells and circulating endothelial cells (CTCs/CECs) in patients with HER2-negative recurrent or metastatic breast cancer treated with bevacizumab (B) in combination with paclitaxel (P) and gemcitabine (G) as first-line therapy (AVALUZ trial)

Study of the usefulness of angiotensin type 1 receptor (AGTR1) as a possible response predictor in patients with metastatic breast cancer (mBC) subjected to chemotherapy and treatment with bevacizumab (AVALUZ Study)

Bioengineering commensal bacteria-derived outer membrane vesicles for delivery of biologics to the gastrointestinal and respiratory tract

Mixed Iodide–Bromide Methylammonium Lead Perovskite-based Diodes for Light Emission and Photovoltaics

A first order hyperbolic framework for large strain computational solid dynamics. Part I: Total Lagrangian isothermal elasticity

Reduction of faecal immunochemical test false‐positive results using a signature based on faecal bacterial markers

El futbol, nova potència social, econòmia i política

L'arxiver de la Diputació

Suchergebnisse filtern